Microbiome Sequencing Services Market 2021 | Demand, Size, Trends, Growth and Forecast by 2026

According to the latest report by IMARC Group, titled, “Microbiome Sequencing Services Market Trends: Global Industry, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global microbiome sequencing services market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 21% during 2021-2026.

Microbiome sequencing services aid in determining the function of the microbiome in human health and disease pathogenesis by utilizing next-generation sequencing (NGS) instruments. They primarily include functional profiling, alpha-diversity, beta-diversity, virulence factor identification, LEfSe biomarker discovery, clustering heatmap, etc. These services offer comprehensive bioinformatics and statistical analyses in an interactive and user-friendly report, along with faster and more accurate classification compared to conventional identification methods, such as cloning and culturing.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/microbiome-sequencing-services-market/requestsample

Market Trends

The expanding pharmaceutical sector across the globe is among the key factors driving the microbiome sequencing services market. Moreover, the rising prevalence of colorectal cancer (CRC) owing to various factors, including the increasing occurrences of inflammatory intestinal conditions and consumption diets with low fiber and high fat content, is further stimulating the market growth. Apart from this, the escalating demand for early disease detection and diagnosis is further augmenting the global market. Furthermore, the growing applications of microbiome sequencing services in academia and research institutes for protein and small molecule analysis are catalyzing the product demand. Additionally, microbiome content is widely gaining traction as a biomarker for different diseases owing to faster and cost-effective sequencing platforms and data analysis pipelines, which is propelling the market. Besides this, the increasing focus on customizing gut microbial consortia to develop advanced individualized medicine, coupled with advancements in genomic research, are expected to drive the microbiome sequencing services market over the forecasted period.

NoteWe are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

  • BaseClear B.V.
  • Clinical-Microbiomics A/S
  • Diversigen Inc (OraSure Technologies Inc.)
  • Mérieux NutriSciences
  • Metabiomics Corporation (BioSpherex LLC)
  • Microbiome Insights Inc.
  • Microbiome Therapeutics LLC
  • Molecular Research LP
  • Molzym GmbH & Co. KG
  • Resphera Biosciences LLC
  • Shanghai Realbio Technology (RBT) Co. Ltd.
  • Zymo Research Corporation.

The report has segmented the market based on technology, research type, laboratory type, application and end user.

Breakup by Technology:

  • Sequencing by Synthesis (SBS)
  • Sequencing by Ligation (SBL)
  • Pyrosequencing
  • Sanger Sequencing
  • Others

Breakup by Research Type:

  • Outsourced Research
  • Internal Research

Breakup by Laboratory Type:

  • Dry Labs
  • Wet Labs

Breakup by Application:

  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • RNA Sequencing
  • Whole Genome Sequencing
  • Others

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes
  • Others

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Table of Content:

1    Preface
2    Scope and Methodology

2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

4.1    Overview
4.2    Key Industry Trends
5    Global Microbiome Sequencing Services Market
5.1    Market Overview
5.2    Market Performance
5.3    Impact of COVID-19
5.4    Market Forecast
6    Market Breakup by Technology
6.1    Sequencing by Synthesis (SBS)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2    Sequencing by Ligation (SBL)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3    Pyrosequencing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4    Sanger Sequencing
6.4.1 Market Trends
6.4.2 Market Forecast
6.5    Others
6.5.1 Market Trends
6.5.2 Market Forecast
7    Market Breakup by Research Type
7.1    Outsourced Research
7.1.1 Market Trends
7.1.2 Market Forecast
7.2    Internal Research
7.2.1 Market Trends
7.2.2 Market Forecast
8    Market Breakup by Laboratory Type
8.1    Dry Labs
8.1.1 Market Trends
8.1.2 Market Forecast
8.2    Wet Labs
8.2.1 Market Trends
8.2.2 Market Forecast
9    Market Breakup by Application
9.1    Shotgun Sequencing
9.1.1 Market Trends
9.1.2 Market Forecast
9.2    Targeted Gene Sequencing
9.2.1 Market Trends
9.2.2 Market Forecast
9.3    RNA Sequencing
9.3.1 Market Trends
9.3.2 Market Forecast
9.4    Whole Genome Sequencing
9.4.1 Market Trends
9.4.2 Market Forecast
9.5    Others
9.5.1 Market Trends
9.5.2 Market Forecast
10    Market Breakup by End User
10.1    Pharmaceutical and Biotechnology Companies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2    Research and Academic Institutes
10.2.1 Market Trends
10.2.2 Market Forecast
10.3    Others
10.3.1 Market Trends
10.3.2 Market Forecast
11    Market Breakup by Region
11.1    North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2    Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3    Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4    Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5    Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12    SWOT Analysis
12.1    Overview
12.2    Strengths
12.3    Weaknesses
12.4    Opportunities
12.5    Threats
13    Value Chain Analysis
14    Porters Five Forces Analysis

14.1    Overview
14.2    Bargaining Power of Buyers
14.3    Bargaining Power of Suppliers
14.4    Degree of Competition
14.5    Threat of New Entrants
14.6    Threat of Substitutes
15    Price Analysis
16    Competitive Landscape

16.1    Market Structure
16.2    Key Players
16.3    Profiles of Key Players
16.3.1    BaseClear B.V.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2    Clinical-Microbiomics A/S
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3    Diversigen Inc (OraSure Technologies Inc.)
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4    Mérieux NutriSciences
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5    Metabiomics Corporation (BioSpherex LLC)
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6    Microbiome Insights Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7    Microbiome Therapeutics LLC
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8    Molecular Research LP
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9    Molzym GmbH & Co. KG
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10    Resphera Biosciences LLC
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11    Shanghai Realbio Technology (RBT) Co. Ltd.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12    Zymo Research Corporation
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Website: https://www.imarcgroup.com
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800

About MarcelMikaelson

Check Also

7 Top-Notch EMF Products for a Safer Environment

Highlights Understand EMF Radiation’s two types – extremely low frequency (ELF) and radio frequency (RF). …

Leave a Reply

Your email address will not be published. Required fields are marked *